Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact

Citations to this article

Multiple cancer-specific antigens are targeted by a chimeric antigen receptor on a single cancer cell
Yanran He, … , David M. Kranz, Hans Schreiber
Yanran He, … , David M. Kranz, Hans Schreiber
Published December 5, 2019
Citation Information: JCI Insight. 2019;4(23):e135306. https://doi.org/10.1172/jci.insight.135306.
View: Text | PDF | Amended Article
Corrigendum

Multiple cancer-specific antigens are targeted by a chimeric antigen receptor on a single cancer cell

  • Text
  • PDF
Abstract

Authors

Yanran He, Karin Schreiber, Steven P. Wolf, Frank Wen, Catharina Steentoft, Jonathan Zerweck, Madeline Steiner, Preeti Sharma, H. Michael Shepard, Avery Posey, Carl H. June, Ulla Mandel, Henrik Clausen, Matthias Leisegang, Stephen C. Meredith, David M. Kranz, Hans Schreiber

×

Total citations by year

Year: 2025 2023 2022 2021 2020 Total
Citations: 1 2 4 5 3 15
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (15)

Title and authors Publication Year
Differential expression of CD175 and CA19-9 in pancreatic adenocarcinoma
Cheng JJ, Matsumoto Y, Dombek GE, Stackhouse KA, Ore AS, Glickman JN, Heimburg-Molinaro J, Cummings RD
Scientific Reports 2025
Novel banana lectin CAR-T cells to target pancreatic tumors and tumor-associated stroma.
McKenna MK, Ozcan A, Brenner D, Watanabe N, Legendre M, Thomas DG, Ashwood C, Cummings RD, Bonifant C, Markovitz DM, Brenner MK
Journal for ImmunoTherapy of Cancer 2023
Targeting Solid Cancers with a Cancer-Specific Monoclonal Antibody to Surface Expressed Aberrantly O-glycosylated Proteins
Aasted MK, Groen AC, Keane JT, Dabelsteen S, Tan E, Schnabel J, Liu F, Lewis HG, Theodoropulos C, Posey AD Jr, Wandall HH
Molecular cancer therapeutics 2023
Roles of Podoplanin in Malignant Progression of Tumor
H Suzuki, M Kaneko, Y Kato
Cells 2022
Mitochondrial regulation during male germ cell development
X Wang, L Yin, Y Wen, S Yuan
Cellular and Molecular Life Sciences 2022
Mining the Immunopeptidome for Antigenic Peptides in Cancer.
León-Letelier RA, Katayama H, Hanash S
Cancers 2022
Chimeric antigen receptor T cells applied to solid tumors
Zhou Z, Tao C, Li J, Tang JC, Chan AS, Zhou Y
Frontiers in immunology 2022
Recent advances and discoveries in the mechanisms and functions of CAR T cells
RC Larson, MV Maus
Nature Reviews Cancer 2021
Antigen multimers: Specific, sensitive, precise, and multifunctional high-avidity CAR-staining reagents
Y Hu, G Cao, X Chen, X Huang, N Asby, N Ankenbruck, A Rahman, A Thusu, Y He, PA Riedell, MR Bishop, H Schreiber, JP Kline, J Huang
2021
Emerging glyco‐based strategies to steer immune responses
M Anderluh, F Berti, A BzduchaWróbel, F Chiodo, C Colombo, F Compostella, K Durlik, X Ferhati, R Holmdahl, D Jovanovic, W Kaca, L Lay, M MarinovicCincovic, M Marradi, M Ozil, L Polito, JJ ReinaMartin, CA Reis, R Sackstein, A Silipo, U Švajger, O Vaněk, F Yamamoto, B Richichi, SJ Vliet
The FEBS journal 2021
Novel antigens of CAR T cell therapy: New roads; old destination
PS Kozani, PS Kozani, F Rahbarizadeh
Translational oncology 2021
A Novel Treatment for Ewing’s Sarcoma: Chimeric Antigen Receptor-T Cell Therapy
Z Lin, Z Wu, W Luo
Frontiers in immunology 2021
Targeting Senescent Cells for a Healthier Aging: Challenges and Opportunities
S Song, T Tchkonia, J Jiang, JL Kirkland, Y Sun
Advanced Science 2020
Use of Cell and Genome Modification Technologies to Generate Improved “Off-the-Shelf” CAR T and CAR NK Cells
MA Morgan, H Büning, M Sauer, A Schambach
Frontiers in immunology 2020
Structure-guided engineering of the affinity and specificity of CARs against Tn-glycopeptides
P Sharma, VV Marada, Q Cai, M Kizerwetter, Y He, SP Wolf, K Schreiber, H Clausen, H Schreiber, DM Kranz
Proceedings of the National Academy of Sciences 2020

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts